相关实验视频

Updated: May 22, 2025

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

寻找TNBC疫苗的搜索:守护疫苗的守护者

Cory Fines¹, Helen McCarthy¹, Niamh Buckley¹

¹School of Pharmacy, Queen's University Belfast, Belfast, UK.

Cancer biology & therapy

|March 16, 2025

概括

三阴性乳腺癌 (TNBC) 的存活率很低,需要新的治疗方法. 本综述探讨了有希望的TNBC疫苗,强调p53作为免疫治疗的关键抗原.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
疫苗开发疫苗开发

背景情况:

乳腺癌是主要的癌症诊断,三阴性乳腺癌 (TNBC) 占病例的15-20%.
TNBC的特点是缺乏雌激素受体 (ER),孕激素受体 (PR) 和HER2放大.
尽管初始化疗反应较高,但由于临床和分子异质性,TNBC的生存率最低.

研究的目的:

审查TNBC免疫疗法的当前进展.
突出TNBC疫苗作为一种新的治疗策略的潜力.
确定p53作为TNBC疫苗开发的有希望的抗原.

主要方法:

对TNBC免疫疗法现有研究的文献综述.
免疫检查点抑制剂和疫苗策略的分析.
对潜在的TNBC特异性抗原的评估.

主要成果:

免疫疗法,包括免疫检查点抑制剂,对TNBC治疗有希望.
对于TNBC疫苗来说,这是一个令人兴奋和不断发展的研究领域.
抗原p53被确定为TNBC疫苗的高度相关的标.

结论:

新的治疗策略对于改善TNBC患者的治疗结果至关重要.
基于疫苗的免疫疗法对TNBC具有显著的潜力.
准p53抗原可能导致有效的TNBC疫苗.

关键词:

三重阴性乳腺癌是什么?免疫疗法免疫疗法它们是mRNARNA.在 p53 里,p53 是一个 p53 的类型.疫苗疫苗疫苗疫苗

更多相关视频

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccinations

Vaccinations

Cross-reactivity

Cross-reactivity

Active versus Passive Immunity

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...